Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS. Zimmermann M, Sanderson N S, Rasenack M, Lalive PH, Lang AB, Curtin F, Lindberg RLP, Kappos L, Derfuss T Neurol Neuroimmunol Neuroinflamm. 2015 Oct; 2(5):e144. Epub 2015 Aug 20. PMID: 26380353. Abstract CommentRecommendBookmarkWatch